CPMV · Mosaic ImmunoEngineering Inc. · Executive Compensation
$0.33
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The above matters raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$441,770
Shares
7.24M
Volume · Oct 9
1700
Avg daily vol (3M)
1217
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carlton Johnson | Board of Directors | Resigned | 2024-07-25 |
| Gloria Felcyn | independent director | Terminated | 2024-04-19 |
| Nicole Steinmetz | acting Chief Scientific Officer | Resigned | 2023-05-03 |
| Nicole Steinmetz | member of the board of directors | Resigned | 2023-05-03 |
Leadership
- Steven King CEO, Board Member
- Paul Lytle CFO, Board Member
- Robert Garnick Board Member